Baxter International (BAX) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sanara MedTech (SMTI) has outperformed Baxter International (BAX) over the past year, gaining 8.4% versus a gain of 5.1%. Over five years, SMTI leads with a +6.3% price change compared with -70.0% for BAX. Baxter International is the larger company by market cap ($12.36 billion vs $322.0 million), about 38.4 times the size.
On valuation, Baxter International trades at a lower forward P/E (11.7x vs 64.9x for Sanara MedTech). Baxter International pays a dividend yielding 0.84%, while Sanara MedTech does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BAX | SMTI |
|---|---|---|
| Share price | $23.90 | $35.05 |
| Market cap | $12.36B | $322.04M |
| 1-day change | -0.29% | 0.00% |
| YTD return | +25.07% | +50.11% |
| 1-year return | +5.05% | +8.41% |
| 5-year return | -70.01% | +6.28% |
| Forward P/E | 11.72 | 64.91 |
| EPS (TTM) | $-1.88 | $-0.04 |
| Dividend yield | 0.84% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $11.24B | — |
| Revenue growth (YoY) | +5.72% | — |
| Net income (latest FY) | $-957.00M | — |
| Gross margin | 30.05% | — |
| Operating margin | -2.74% | — |
| Net margin | -8.51% | — |
| 52-week high | $30.00 | $35.34 |
| 52-week low | $15.73 | $16.05 |
| Distance from 52-week high | -20.33% | -0.82% |
| Analyst consensus | hold | none |
| Avg. price target upside | +16.82% | -0.14% |
| Average volume | 6.66M | 280.40K |
| Shares outstanding | 517.00M | 9.19M |
| Employees | 37,500 | 108 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Baxter International is about 38.4 times larger than Sanara MedTech by market value ($12.36B vs $322.04M).
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Healthcare · Medical Instruments & Supplies · 37,500 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Healthcare · Medical Instruments & Supplies · 108 employees
BAX vs SMTI FAQ
Which is bigger, Baxter International or Sanara MedTech?
Baxter International (BAX) is larger, with a market capitalization of $12.36B compared with $322.04M for Sanara MedTech (SMTI).
Which stock has performed better over the past year, BAX or SMTI?
SMTI returned +8.41% over the past 12 months, compared with +5.05% for BAX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Baxter International or Sanara MedTech?
Baxter International pays a dividend yielding 0.84%, while Sanara MedTech does not currently pay a regular dividend.
Are Baxter International and Sanara MedTech in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.